A randomised, multicentric, open labelled, parallel group trial with insulin aspart and insulin detemir, investigating the glycaemic effect and profile in children with Type 1 diabetes, of two separate Levemir® + NovoRapid® injections and extemporaneous mixing. THE Paediatric MIXING TRIAL The primary objective of the trial is to assess if using insulin detemir mixed with insulin aspart in the same syringe and 2 separates injections of insulin detemir and insulin aspart will have any cl...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

To assess ease of use, acceptability and preference of Norditropin NordiFlex® in subjects on prescribed growth hormone therapy The primary objective of this study is to investigate how easy/difficult patients/parents assess growth hormone injection using Norditropin NordiFlex® by quantifying the proportion of patients that fi...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Levemir® in ageing patients with type 2 diabetes A seven-month open-labelled randomised multi-centre two-group parallel trial comparing administration of insulin detemir once daily in the morning versus NPH insulin once daily in the morning in ageing subjects with type 2 diabetes. The 3L Study (Levemir in Late Life) Trial Phase: 4 The aim of the study is to compare two -basal insulin regimens as insulin therapy initiation in ageing type 2 diabetic patients with insulin detemir versus NPH insulin given once daily in the morning.

• Pays Aucun
• Organes Aucun
• Spécialités Aucune